27.12% 0.6701

Co Diagnostics Inc (CODX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Co Diagnostics Inc Stock (CODX) Company Profile

Co Diagnostics Inc

Healthcare (1117)

Medical Devices (139)

Prossima data di guadagno

Ultimi documenti SEC

CODX's Discussions on Twitter

Compare CODX vs ABT, SYK, MDT, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CODX Co Diagnostics Inc	3.04	0	507.90K	-32.18M	-31.81M	-21.91
ABT Abbott Laboratories	110.50	192.10B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	347.43	137.25B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	89.08	115.41B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	69.06	103.81B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	84.73	49.82B	6.07B	1.06B	1.34B	1.8063

Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-08-12	Downgrade	Sidoti	Buy → Neutral
2021-12-29	Iniziato	Sidoti	Buy
2021-03-29	Downgrade	Maxim Group	Buy → Hold
2020-05-20	Aggiornamento	Maxim Group	Hold → Buy
2020-05-18	Reiterato	H.C. Wainwright	Buy
2020-03-09	Reiterato	H.C. Wainwright	Buy
2020-03-03	Downgrade	Maxim Group	Buy → Hold

Mostra tutto

Co Diagnostics Inc Borsa (CODX) Ultime notizie

Co Diagnostics Inc Azioni (CODX) Dati Finanziari

Co Diagnostics Inc (CODX)

Co Diagnostics Inc Stock (CODX) Company Profile

Compare CODX vs ABT, SYK, MDT, BSX, EW

Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades

Co Diagnostics Inc Borsa (CODX) Ultime notizie

Co-Diagnostics Regains Nasdaq Compliance and Listing Status - TipRanks

Co-Diagnostics regains Nasdaq listing compliance - Investing.com

Co-Diagnostics regains Nasdaq listing compliance By Investing.com - Investing.com UK

Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements - PR Newswire

Fundamentals Check: Will Co Diagnostics Inc benefit from rising consumer demandJuly 2025 Gainers & Daily Momentum Trading Reports - baoquankhu1.vn

CODX Stock Jumped A Whopping 148% Today: What’s Driving The Super Rally? - Stocktwits

Establishment Labs and Co-Diagnostics: A Comparison of Medical Companies - National Today

Inside Dubai's World Health Expo, Co-Diagnostics meets MENA lab leaders - Stock Titan

India grants license for CoSara PCR device; TB, HPV tests pending - Stock Titan

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform - Morningstar

Co-Diagnostics (CODX) Downgraded to Hold by Maxim Group Today | - GuruFocus

Co-Diagnostics Shares Transition to Over-the-Counter Trading - AD HOC NEWS

Co-Diagnostics Faces Nasdaq Delisting After Bid Price Noncompliance - The Globe and Mail

CODX Stock Price, Forecast & Analysis | CO-DIAGNOSTICS INC (NASDAQ:CODX) - Chartmill

Co-Diagnostics (CODX) Price Target Increased by 2,900.00% to 38.25 - Nasdaq

Co-Diagnostics to be delisted from Nasdaq, trading to move to OTC Market By Investing.com - Investing.com India

Co-Diagnostics to be delisted from Nasdaq, trading to move to OTC Market - Investing.com Nigeria

Co-Diagnostics Received Notice of Delisting - TradingView — Track All Markets

Co-Diagnostics, Inc.(OTCPK: CODX) dropped from NASDAQ Composite Index - marketscreener.com

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships - StreetInsider

Why Co Diagnostics Inc. stock could be next big winnerShare Buyback & Stepwise Trade Execution Plans - Улправда

CODX stock plunges to all-time lows on 1-for-30 reverse stock split approval - MSN

Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention and Expo on Oct 2-3 - marketscreener.com

CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform - Finviz

Co-Diagnostics Approves Reverse Stock Split to Maintain Listing - The Globe and Mail

Co-Diagnostics announces 1-for-30 reverse stock split - Yahoo Finance

Institution Moves: Is Co Diagnostics Inc stock a buy in volatile marketsDip Buying & Daily Volume Surge Trade Alerts - moha.gov.vn

Co-Diagnostics (CODX) Announces 1-for-30 Reverse Stock Split - GuruFocus

Co-Diagnostics to Effect a 1-for-30 Reverse Stock Split - MarketScreener

CODX Stock Plunges To All-Time Lows On 1-for-30 Reverse Stock Split Approval - Stocktwits

Co-Diagnostics stock plunges after announcing 1-for-30 reverse split By Investing.com - Investing.com South Africa

Co-Diagnostics announces 1-for-30 reverse stock split By Investing.com - Investing.com Nigeria

Co-Diagnostics stock plunges after announcing 1-for-30 reverse split - Investing.com Canada

Co-Diagnostics Announces Reverse Stock Split - Financial Times

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies - The Malaysian Reserve

Co-Diagnostics Receives Grant of Australian Patent Covering Co-D - GuruFocus

Co-Diagnostics (CODX) Secures Australian Patent for PCR Platform - GuruFocus

Co-diagnostics receives Australian patent for PCR testing platform By Investing.com - Investing.com India

Co-diagnostics receives Australian patent for PCR testing platform - Investing.com

Co-Diagnostics Q3 2025 Earnings Preview - MSN

Can Co-Diagnostics Stock Recover If Markets Fall? - Trefis

Aug Breakouts: How resilient is Co Diagnostics Inc. stock in market downturns - Улправда

Co Diagnostics Inc Azioni (CODX) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a CODX